Use of Digital Droplet PCR for Detecting EGFR T790M Resistance Mutation in Plasma at Progression on TKI Therapy

被引:0
|
作者
Jonsson, M. [1 ]
Planck, M. [2 ]
Reutersward, C. [1 ]
Nilsson, I. [2 ]
Carlsson, M. [2 ]
George, A. [1 ]
Saal, L. [1 ]
Staaf, J. [1 ]
Isaksson, S. [1 ]
机构
[1] Div Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden
[2] Skane Univ Hosp, Dept Resp Med & Allergol, Lund, Sweden
关键词
plasma; EGFR; ddPCR;
D O I
10.1016/j.jtho.2019.08.2301
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP1.14-16
引用
收藏
页码:S1037 / S1038
页数:2
相关论文
共 50 条
  • [21] Comparative analysis of QS3D versus droplet digital PCR for quantitative measures of EGFR T790M mutation from identical plasma
    Guo, Qiaomei
    Wang, Lin
    Liang, Xiaohui
    Zhao, Mingna
    Huang, Xia
    Xu, Wanxing
    Lou, Jiatao
    Qiao, Lihua
    HELIYON, 2022, 8 (11)
  • [22] Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation
    Oya, Yuko
    Yoshida, Tatsuya
    Kuroda, Hiroaki
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Inaba, Yoshitaka
    Hida, Toyoaki
    Yatabe, Yasushi
    CLINICAL LUNG CANCER, 2017, 18 (06) : 698 - +
  • [23] Direct digital polymerase chain reaction chip for the detection of EGFR T790M mutation in plasma
    Xia, Liping
    Zhuang, Jianjian
    Zou, Zheyu
    Yin, Juxin
    Mu, Ying
    TALANTA, 2022, 237
  • [24] Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
    Zhao, S.
    Jiang, T.
    Li, X.
    Zhao, C.
    Su, C.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S410 - S410
  • [25] T790M MUTATION ASSOCIATED WITH BETTER EFFICACY OF CONTINUOUS EGFR-TKI TREATMENT IN ADVANCED NSCLC PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKI
    Ren, Shengxiang
    Li, Wei
    Li, Aiwu
    Chen, Xiaoxia
    Gao, Guanghui
    He, Yayi
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1084 - S1084
  • [26] Detection of T790M mutation in EGFR gene, an EGFR-TKI resistant mutation, in tumor samples unexposed to EGFR TKIs
    Koba, Hayato
    Kimura, Hideharu
    Nishikawa, Shingo
    Yoneda, Taro
    Sone, Takashi
    Kasahara, Kazuo
    CANCER RESEARCH, 2016, 76
  • [27] T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
    Li, Wei
    Ren, Shengxiang
    Li, Jiayu
    Li, Aiwu
    Fan, Lihong
    Li, Xuefei
    Zhao, Cao
    He, Yayi
    Gao, Guanghui
    Chen, Xiaoxia
    Li, Shuai
    Shi, Jingyun
    Zhou, Caicun
    Fei, Ke
    Schmid-Bindert, Gerald
    LUNG CANCER, 2014, 84 (03) : 295 - 300
  • [28] Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
    Wang, Zhijie
    Chen, Rui
    Wang, Shuhang
    Zhong, Jia
    Wu, Meina
    Zhao, Jun
    Duan, Jianchun
    Zhuo, Minglei
    An, Tongtong
    Wang, Yuyan
    Bai, Hua
    Wang, Jie
    PLOS ONE, 2014, 9 (11):
  • [29] A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance
    Wang, Wenxian
    Song, Zhengbo
    Zhang, Yiping
    Jin, Ying
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1211 - S1211
  • [30] Detection of EGFR T790M Mutation by Droplet Digital Polymerase Chain Reaction in Lung Carcinoma Cytology Samples
    Nizamaddin, Shara Kamil
    Mehrotra, Meenakshi
    Nadhim, Ari Sami H.
    Luthra, Rajyalakshmi
    Roy-Chowdhuri, Sinchita
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2020, 144 (08) : 997 - 1002